TriangleRadiation + Radioactive Iodine (NCT04892303)
Radiation + Radioactive Iodine trial for Recurrent Differentiated Thyroid Cancer (NCT04892303). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adults with differentiated thyroid cancer that has come back and cannot be completely removed by surgery.
The idea: combine two kinds of radiation. Radioactive iodine treats tumors from inside the body, and external beam radiation adds a planned dose to up to three tumors. Careful dose planning aims to make the combination safe while giving tumors higher doses.
This phase 1 study plans 48 patients and measures safety. At Johns Hopkins in Baltimore, Harry Quon leads it.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.